STOCK TITAN

Sartorius Stedim Biotech S.A./ADR (SDMHF) SEC Filings

SDMHF OTC
Rhea-AI Summary

Sartorius Stedim Biotech S.A./ADR (SDMHF) registered 50,000,000 American Depositary Shares representing ordinary shares of Sartorius Stedim Biotech S.A. The fee table lists a proposed maximum aggregate price per unit of $0.10 and a proposed maximum aggregate offering price of $5,000,000, estimated solely to calculate the registration fee; the stated fee is $690.50.

The Bank of New York Mellon is the depositary. The registration statement represents that the foreign issuer publishes information contemplated under Rule 12g3-2(b), based on the depositary’s reasonable good-faith belief after limited investigation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.70%
Tags
other
-
Rhea-AI Summary

Sartorius Stedim Biotech S.A./ADR registered 50,000,000 American Depositary Shares (ADSs) through JPMorgan Chase Bank, N.A. as depositary; each ADS represents one-tenth of one ordinary share. The fee table lists a proposed maximum price of $0.10 per ADS and a proposed maximum aggregate offering price of $5,000,000, both estimated solely to calculate the registration fee. The deposit agreement describes holder rights, fees, voting and dividend procedures, and deposit and withdrawal restrictions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.38%
Tags
other
-
F-6 POS
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
other

FAQ

How many Sartorius Stedim Biotech S.A./ADR (SDMHF) SEC filings are available on StockTitan?

StockTitan tracks 3 SEC filings for Sartorius Stedim Biotech S.A./ADR (SDMHF). Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Sartorius Stedim Biotech S.A./ADR (SDMHF)?

The most recent SEC filing for Sartorius Stedim Biotech S.A./ADR (SDMHF) was filed on April 22, 2026.